MEIBOMIAN GLAND DYSFUNCTION: WHERE DRY EYE BEGINS

Similar documents
Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work?

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD

Microblepharoexfoliation for the Surgical Dry Eye Patient. Frank W. Bowden, III, M.D., FACS

MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY?

1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India

Understanding the Role of Meibomian Gland Dysfunction in Dry Eyes

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

A DRY EYE DISEASE DECISION TREE

Meibomian gland dysfunction

Dry eye disease was recently redefined as a multifactorial

Evidence for Technology in the Treatment of Advanced Dry Eye

DRY EYE and MGD. Contact Central Maryland Eye Associates Today.

Dry Eye Syndrome (DES)

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Financial Disclosures

IPL for the management of MGD/DED. Dr. Jeffrey Judelson, FRCSC

Meibomian gland dysfunction (MGD) may well be the leading

Dry Eye Disease Update

Advanced Diagnosis and Management of OSD and Tear Dysfunction

Tear Structure. Structure = Stability. Disclosures. In Depth Management of Ocular Surface & Tear Film Disorders UNDERSTANDING THE OCULAR SURFACE

1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

DRY EYE INFORMATION AND TREATMENTS

The first comprehensive definition of DED was published in

Tear Osmolarity and its role in Optometric Practice & Contact Lens Success

pat hways Medtech innovation briefing Published: 21 April 2015 nice.org.uk/guidance/mib29

PROFILE OF MEIBOMIAN GLANDS IN MEIBOMIAN GLAND DYSFUNCTION

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

No Conflict of Interest to Report Charles Stockwell, O.D

Topical diquafosol for patients with obstructive meibomian gland dysfunction

1/23/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

RECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

Learn Connect Succeed. JCAHPO Regional Meetings 2017

A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction

Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction

Scottish Dry Eye Guidelines

The Tear Film! Cataract Surgery in the Diseased Eye: Ocular Surface Disease

Consulting Bausch+Lomb/Valeant, NovaBay (Avenova), Google, Allergan, Vistakon, Alcon

Ocular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO

UNDERSTANDING DRY EYE TREATMENT AND PROTOCOL

A Clinical Study of Meibomian Gland Dysfunction in Patients with Diabetes in Bundelkhand region

How to Create a Dry Eye Center

John Rawstron Christchurch 2015

MANAGING THE LID MARGIN AND LASHES: IN-OFFICE PROCEDURES. Scott Schachter, OD Pismo Beach, CA

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

Visionary Optics. SynergEyes. North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois. S. Barry Eiden, OD, FAAO

Prevalence of Dry Eye Disease

Meibomian gland Dropout in Chinese cataract patients.

Chalazia can recur, and those that do should be evaluated for malignancy.

DRY EYE TAKING AIM. How Systematic Management of this Chronic Disease is Improving Patient Outcomes. Sponsored by. A Supplement to

10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye

Learning Objectives. Disclosures 2/2/ BMT Pharmacists Conference Bandage Contact Lens Therapy for Severe Ocular GVHD

Dry Eyes The mucin layer

Current Treatment and Management of Dry Eye

Meibomian gland dysfunction: hyperkeratinization or atrophy?

a.superficial (adenoid layer).contain lymphoid tissue.


Dry Eye Prescribing Guidelines

Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction

Prevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy

HELP HEAL YOUR PATIENTS DRY EYES.

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6

Cool approach to managing hot lids

1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation.

Meibomian gland dysfunction (MGD) is a chronic abnormality

Childhood corneal neovascularization

Correlation of Bacterial Burden, Meibomian Gland Dysfunction and Ocular Surface Disease

Incidence Of Dry Eye Disesase In People Living With Acquired Immuodeficiency Synrome

Evaluation of Dry Eye: A Hospital Based Study

Dry Eye Syndrome Prescribing Guidelines

Vision Health: Conditions, Disorders & Treatments EYELID DISORDERS

OVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Need for Animal Models of Meibomian Gland Dysfunction

Pardon the Objection: Cases Marc R. Bloomenstein OD, FAAO Scot Morris, OD Derek Cunningham, OD Kathy Mastrota, OD

Ocular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It

Anatomy: There are 6 muscles that move your eye.

Doxycycline for stye on eye

Meibomian Gland Dysfunction

4/20/2014. Building Dry Eye Service Line. Mike Trier. Financial Disclosure. Approach of This Talk. Mike Trier No Financial Interest

Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH

World innovation for dry-eye syndrome using a new pulsed light technology: IRPL

Conjunctivitis in Cats

Breaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai

Nasolacrimal Duct Blockage

DEWS Severity Analysis 11/30/12. Blephari/s, MGD and Ocular Surface Disease. Ben Gaddie, O.D., F.A.A.O. Louisville, KY

In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction

OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR.

Objective image analysis of the meibomian gland area

Scheffer C.G. Tseng, MD, PhD

Transcription:

MEIBOMIAN GLAND DYSFUNCTION: WHERE DRY EYE BEGINS Craig Thomas, O.D. 3900 West Wheatland Road Dallas, Texas 75237 972-780-7199 thpckc@yahoo.com COPE Course #61212-AS FINANCIAL DISCLOSURES I am a paid consultant for the following companies: Konan Medical Optovue, Inc. These affiliations will not affect the content of this presentation DRY EYE DISEASE It is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles. To determine a diagnosis of dry eye disease, symptoms that suggest the presence of dry eye syndrome must be present and positive scores in any of the following three measurements must be present Tear film stability Tear film osmolarity Ocular surface staining Severe dry eye disease with major impact on quality of life can affect up to 10% of the population over 50-years-old Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15 (3):276-283. 1 2 3 NATURAL HISTORY OF DRY EYE DISEASE The disease evolves in a sequence of four milestones 1. Loss of water from the tear film with an increase in tear osmolarity 2. Decreased conjunctival goblet cell density and decrease corneal glycogen produce increased conjunctival epithelial desquamation 3. Increased corneal epithelial desquamation 4. Destabilization of the cornea-tear interface LOSS OF WATER FROM THE TEAR FILM Loss of water from the precorneal tear film results in decreased tear film volume and is associated with debris in the tear film Dehydrated mucus that has precipitated in to the inferior fornix indicates severe loss of water from the tear film Abnormal increase in conjunctival sloughing results in immature conjunctival epithelial cells moving onto the surface of the eye CONJUNCTIVAL DESQUAMATION As the desquamation accelerates, the damaged cells release inflammatory mediators onto the surface of the eye and the inflammatory process begins 4 5 6 1

CORNEAL EPITHELIAL DESQUAMATION Continued exposure to the osmotic gradient produced by high tear film osmolarity will eventually damage the corneal epithelium As corneal desquamation accelerates, the damaged cells perpetuate the inflammatory process by releasing inflammatory mediators onto the ocular surface DESTABILIZATION OF THE CORNEA-TEAR INTERFACE Abnormal tear film break-up time indicates tear film instability secondary to loss of epithelial microvilli The corneal epithelial changes required to cause tear film instability occur late in the natural history of dry eye syndrome 7 8 9 WHY IS THERE A LOSS OF WATER FROM THE TEAR FILM The literature reports that up to 86% of people with dry eye disease have clinical signs of Meibomian Gland Dysfunction Requirements for diagnosis*** Determination ofexpressibility Measurement of TBUT Evaluation of gland structure It is appropriate to include gland expression by the application of moderate digital pressure to the central lower eyelid during the eye exam Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012 May;31(5):472-478. doi: 10.1097/ICO.0b013e318225415a. MEIBOMIAN GLAND DYSFUNCTION Meibomian gland dysfunction (MGD) is a chronic, diffuse abnormality of the meibomian glands, commonly characterized by terminal duct obstruction and/or qualitative/quantitative changes in glandular secretions. It may result in alteration of the tear film, symptoms of eye irritation, clinically apparent inflammation, and ocular surface disease. Most prominent clinical aspects of meibomian gland dysfunction Obstruction of meibomian gland orifices and terminalducts Qualitative and/or quantitative changes in meibomian gland secretions such as increased meibum viscosity or loss of meibum transparency Consequence of insufficient lipids in the precorneal tear film Increased tear film evaporation with subsequenthyperosmolarity Tear film instability Increased bacterial growth on the eyelid margin Ocular surface damage and inflammation Nichols K, Foulks G, Bron A, Glasgow B, Dogru M, Tsubota K, Lemp M, Sullivan D. The International Workshop on MeibomianGland Dysfunction:Executive Summary. Investigative Ophthalmology and Visual Science. March 2011, Vol 52, 1922-1929. doi:10.1176/iovs.10-6997a Meibomian glands are large sebaceous glands located in the tarsal plates of the eyelids The glands actively synthesize and secrete lipids and proteins that are delivered at the upper and lower eyelid margins Each meibomian gland consists of the following Multiple secretory acini-containing meibocytes Lateral ductules A central duct A terminal excretory duct that opens at the posterior eyelid margin in an orifice Argueso P. Proteolytic Activity in the Meibomian Gland: Implication to Health and Disease. Exp Eye Res. 2017 Oct: 163: 53-57. doi: 10. 1016/j.exer.2017.03.001 Glands imaged with meibography 10 11 12 Risk Factors for MGD The number of meibomian glands declines with age Mechanism is unclear* Biofilm theory Contact lens wear Allergic conjunctivitis and other external ocular diseases Long-term use of eyedrops to treat glaucoma Auto-immune diseases Smoking Machalinska A, Zakrzewska A, Safranow K, Wiszniewska B, Machalinski B. Risk Factors and Symptoms of Meibomian Gland Loss in a Healthy Population. J Ophthalmol. 2016;2016: 7526120. doi: [10.1155/2016/7526120] MEIBOMIAN GLAND DYSFUNCTION Arita R, Fukuoka S, Morishige N. New insights into the morphology and function of meibomian glands. Exp Eye Res. 163 (2017) 64-71. http://dx.doi.org/10.1016/j.exer.2017.06.010 2

OBSTRUCTIVE MEIBOMIAN GLAND DYSFUNCTION Requirements for a clinical diagnosis of obstructive meibomian gland dysfunction Medical and ophthalmic history Biomicroscopy eyelid margin or tarsal hyperemia eyelid margin telangiectasia eyelid margin thickening gland orifice metaplasia External examination eyelid tenderness Clinical appearance of severe obstructive meibomian gland dysfunction Eyelid margin hyperemia Tarsal hyperemia Eyelid margin telangiectasia Obstruction of the gland orifices Irregularity of eyelid margin Partial meibomian gland dropout EYELID MARGIN ABNORMALITIES Irregular eyelid margins Plugged meibomian gland orifices Vascular engorgement Antero- or postero-replacement of the MCJ 13 14 15 The gland will initially become obstructed or plugged If a patent meibum outflow tract through the natural orifice is not achieved, the gland will eventually become dilated, truncated and atrophied The location of the damage is dependent upon the location of the ductal obstruction Treatment is focused on re-establishing a patent duct/orifice system Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal probing in patients with obstructive gland dysfunction. Br J Ophthalmol. 2018 Jan; 102(1): 59-68. doi: [10. 1136/bjophthalmol-2016-310097] GLAND EXPRESSION PEARLS Obstructions just inside the orifice distal the first acinus produce a gland without expressible meibum If the obstruction is proximal to the first acinus and there remains a communication between the acinus and the orifice this gland would demonstrate expressible meibum even though there is a proximal obstruction In these glands, if this proximal obstruction is not relieved, the gland tissue behind the obstruction would show elevated intraductal pressure with subsequent atrophy leading to a truncated gland Untreated obstructive meibomian gland dysfunction will lead to atrophy of the glands and is characterized by the following abnormal morphologic features Segments of discontinuous meibomian gland tissue Shortening of glands (i.e., truncated) Whole or partial gland dropout Fading or poorly defined glands Loss of all meibomian gland tissue Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive gland dysfunction. Br J Ophthalmol. 2018 Jan; 102(1):59-68. doi: [10.1136/bjophthalmol-2016-310097] MEIBOMIAN GLAND ATROPHY CONTACT LENS-INDUCED MEIBOMIAN GLAND ATROPHY Although the mechanisms responsible for gland atrophy in contact lens wearers isunclear, researchers have found that shortening of the glands in lens wearers isinitially detected at the distal side of the gland orifices as horizontal line 16 17 18 3

Obstruction of gland orifice or central duct results in stasis of meibum Increased intraductal pressure develops over time Cystic dilation of the central duct damages the gland and its function Atrophy of the secretory acini is characterized by gland dropout MEIBOMIAN GLAND ATROPHY Dark area on tarsal plate indicates total acinar-ductular atrophy The International Workshop on Meibomian Gland Dysfunction WHY IS THE EYELID INFLAMED? Bacteria on the lid margin produce enzymes that aggravate and incite hyperkeratinization of the gland s terminal duct epithelium Meibum viscosity increases due to keratinized cell material mixed with the meibum Obstructive process is influenced by the following factors Age Sex Hormonal disturbances Topical medications Biofilm Theory In dry eye blepharitis syndrome (DEBS), eyelid margin disease involves six steps, which are related to bacterial changes culminating in inflammation 1. Bacterial survival 2. Biofilm formation 3. Over-colonization 4. Quorum-sensing gene activation 5. Virulence factor production 6. Inflammation Rynerson JM, Perry HD. DEBS a unification theory for dry eye and blepharitis. Clinical Ophthalmology 2016:10 2455-2467. doi: 10.2147/OPTH.S114674 Bacterial biofilm forms on the eyelid margin and grows WHY IS THE EYELID INFLAMED? Over-colonization within the mature biofilm leads to quorum-sensing gene activation (i.e., change in pathogenicity) The newly activated genes produce a wide variety of virulence factors, many of which are extremely inflammatory Virulence factors cause low-grade, chronic inflammation on the eyelid surface and eventually within the structures of the margin such as lash follicles, glands and connective tissue, eventually affecting the accessory lacrimal glands as the inflammatory response continues Rynerson JM, Perry HD. DEBS a unification theory for dry eye and blepharitis. Clinical Ophthalmology 2016:10 2455-2467. doi: 10/2147/OPTH.S114674 19 20 21 Hyperkeratinization is a disorder of the cells lining the inside of a hair follicle, where the normal desquamation process is interrupted by an excess of keratin, causing dead skin cells to bond together and cause blockage WHY IS THE EYELID INFLAMED? DRY EYE BLEPHARITIS SYNDROME The disease evolves through a series of four milestones over several decades Small lash bulb becomes inflamed after virulence factor production begins from a bacterial biofilm FOLLICULITIS Recent studies from mouse models re-evaluating the role of hyperkeratinization in meibomian gland dysfunction revealed the following Aging mice show meibomian gland dropout and loss of gland volume similar to aging humans Atrophic meibomian glands showed evidence of epithelial plugging of the orifice without the presence of hyperkeratinization Jester JV, Parfitt GJ, Brown DJ. Meibomian gland dysfunction: hyperkeratinization or atrophy? BMC Ophthalmology 2015 15 (Suppl 1) :156. https://doi.org/10.1186/212886-015-0132-x Stage 1 Follicular Inflammation Stage 2 Meibomian Gland Dysfunction Stage 3 Aqueous Deficiency Stage 4 Eyelid Destruction Rynerson JM, Perry HD. DEBS a unification theory for dry eye and blepharitis. Clinical Ophthalmology 2016:10 2455-2467 The inflammation is characterized by edematous follicular tissue swelling up around the base of the eyelash in a volcano sign As the eyelash grows, small pieces of biofilm adherent to the eyelash will be pulled off of the eyelid margin resulting in what is known as collarettes 22 23 24 4

Cylindrical Dandruff is a manifestation of folliculitis Biofilm accesses the potential space between the lash and the surrounding follicle by extending down along the inert eyelash The biofilm accumulates around the eyelash while still deep within the follicle, effectively sheathing the slow-growing eyelash Because the follicle is usually damaged at this point, the rate of lash growth is slower and the biofilm accumulation effectively results in a pipe-stemming of the eyelash FOLLICULITIS MEIBOMIAN GLAND DYSFUNCTION A layer of biofilm within the gland Inflammatory damage has begun The ductile is probably blocked and decreased lipids or abnormal lipids now make up the secretions Abnormal lipids are characterized by an increased melting point and the secretions become thickened When these glands are expressed, you may see copious amounts of meibofilm (biofilm and abnormal meibomian secretions) A systematic and long-term program of eyelid margin hygiene is the basis of treatment for obstructive meibomian gland disease 1. Application of heat to liquify the meibum Electromechanical or light-based device with manual expression LipiFlow Thermal Pulsation System Home-based warm compresses with digital massage or heated masks 2. Eyelid margin is cleaned mechanically Blepharoexfoliation with electromechanical device Mechanical debridement In-office scraping of margin with spud or spatula Home-based debridement therapy 3. Topical or oral antibiotic/anti-inflammatory therapy 25 26 27 APPLICATION OF HEAT FOR MEIBUM LIQUIFICATION (1) Intense Pulse Light A manual technique using light-based heat and compression to evacuate and clean the secretory passages of the glands (2) A thermoelectric device for evacuation of the meibomian glands that brings glandular secretions to their melting point and expresses the softened meibum via digital massage In-Office Heat-Based Treatment APPLICATION OF HEAT FOR MEIBUM LIQUIFICATION Successful MGD treatment requires the removal of glandular obstructions Removing the altered secretions from the glands removes the source of the virulence factors and subsequent inflammation This procedure can be accomplished by raising the temperature of the meibum so that adequate outflow can be achieved, and then compressing the glands to forcefully express the meibum Meibomian gland compressors with broad jaws relieve occlusions with minimal patient discomfort and can be used on upper or lower eyelids Meibomian gland expression after heat-basedtherapy APPLICATION OF HEAT FOR MEIBUM LIQUIFICATION LipiFlow Thermal Pulsation System An automated technique for evacuation of the meibomian glands using heat and intermittent pressure Promotes evacuation and cleansing of the secretory passages Brings lipid glandular material to its melting point and liquifies the meibum Only FDA-cleared instrument shown to restore meibomian gland function 28 29 30 5

EYELID MARGIN IS CLEANED MECHANICALLY A technique for debridement using a spud, spatula or electromechanical device to scrape the eyelid margin Biofilm and exotoxins are manually removed Bacterial overload is debulked Meibomian glands are unroofed Potential complication is structural microtrauma to the eyelid margin Mechanical Debridement with Spatula Destruction of the biofilm on the eyelid margin can result in the following benefits Removes the source of eyelid inflammation Improves the lipid layer of the tear film Allows the eyelids and the glands to begin the healing process Clinical Applications Dry eye disease Contact lens patients Surgical patients Chronic conjunctivitis EYELID MARGIN IS CLEANED MECHANICALLY A technique that uses an electromechanical device that rotates a PVA sponge soaked in commercial eyelid cleaning solution 31 32 33 ANTI-INFLAMMATORY & ANTIBIOTIC TREATMENT Topical Therapies Lipid-based artificial tears or hypotonic artificial tears Steroid/antibiotic drops Azithromycin drops Steroid drops Lifitegrast or cyclosporine Hypochlorous acid drops, gels, sprays Other eyelid hygiene products Oral Therapies Doxycycline or azithromycin Omega-3 essential fatty acid nutritional supplementation CONCLUSION A multimodal treatment program is the best way to treat dry eye blepharitis syndrome Remove the bacterial biofilm that is causing the inflammatory response in the structures of the eyelid Reduce or eliminate meibomian gland obstruction Reduce or eliminate inflammation on the ocular surface Treat tear film insufficiency with topical lubrication and/or punctal occlusion Design a treatment program to maintain eyelid health Liquify the meibum Clean the eyelid margin Anti-inflammatory and/or antibiotic therapy 34 6